Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
Lemos PA, Lee CH, Degertekin M, Saia F, Tanabe K, Arampatzis CA, Hoye A, van Duuren M, Sianos G, Smits PC, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW. Lemos PA, et al. Among authors: saia f. J Am Coll Cardiol. 2003 Jun 4;41(11):2093-9. doi: 10.1016/s0735-1097(03)00429-7. J Am Coll Cardiol. 2003. PMID: 12798587 Free article. Review.
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases.
Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, Hoye A, Degertekin M, Daemen J, McFadden E, Hofma S, Smits PC, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW. Lemos PA, et al. Among authors: saia f. Circulation. 2003 Jul 22;108(3):257-60. doi: 10.1161/01.CIR.0000083366.33686.11. Epub 2003 Jul 14. Circulation. 2003. PMID: 12860901 Clinical Trial.
Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease.
Arampatzis CA, Lemos PA, Tanabe K, Hoye A, Degertekin M, Saia F, Lee CH, Ruiter A, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feijter P, van Domburg R, Serruys PW. Arampatzis CA, et al. Among authors: saia f. Am J Cardiol. 2003 Aug 1;92(3):327-9. doi: 10.1016/s0002-9149(03)00640-4. Am J Cardiol. 2003. PMID: 12888147 Clinical Trial.
Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study.
Saia F, Lemos PA, Lee CH, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Sianos G, Smits PC, McFadden E, Hofma SH, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW. Saia F, et al. Circulation. 2003 Oct 21;108(16):1927-9. doi: 10.1161/01.CIR.0000096053.87580.CD. Epub 2003 Oct 13. Circulation. 2003. PMID: 14557354 Clinical Trial.
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu TK, McFadden E, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter PJ. Lemos PA, et al. Among authors: saia f. Circulation. 2004 Jan 20;109(2):190-5. doi: 10.1161/01.CIR.0000109138.84579.FA. Epub 2003 Dec 22. Circulation. 2004. PMID: 14691037 Clinical Trial.
349 results